On the afternoon of November 17, 2024, the 2024 China Biopharmaceutical Front-Runners (Front-Runners) 100 list was officially unveiled during the China Pharmaceutical Industry Development Conference & Shanghai International Biopharmaceutical Industry Week – Biopharmaceutical Industry Investment and Financing Forum. METiS Technologies was recognized for the second consecutive year, earning a place on the prestigious “China Biopharmaceutical Front-Runners 100” list, highlighting its continued leadership and innovation in the biopharmaceutical sector.
